Skip to main content
Clear icon
43º

MAN ON A MISSION: Cowboys linebacker Leighton Vander Esch battling for starting role

Cowboys linebacker Leighton Vander Esch practices during training camp in Oxnard, California. (William Caldera, KSAT)

OXNARD, California – Leighton Vander Esch is fighting for his future in football with the Dallas Cowboys, and he knows it.

But the major difference between this year’s camp and previous years: he’s healthy.

Recommended Videos



“I feel the best right now than in the last four years during training camp. I think it’s just a testament to the work I put in during the off season,” Vander Esch said. “Last offseason I was coming off my neck [injury] so I couldn’t train as much. But even then, I should have trained more. This off season, it was go time from the second the season was over for me. I was on that mission that I said I was going to be on.”

His ‘Man on a Mission’ mentality could have easily been fueled by the fact the Cowboys declined to pick up the fifth year of his rookie contract. Vander Esch has only played in 19 games over the last two seasons, after participating in all 16 games his rookie season. Dallas also used their first pick of this year’s draft on a linebacker -- Micah Parsons -- which just ratchets up the pressure to perform in 2021.

RELATED: Cowboys QB Dak Prescott discusses right shoulder soreness

“You have to prove yourself every year. You have to prove yourself every snap. Otherwise you ain’t going to last long.”

One of the biggest reasons Vander Esch enters this season in new form is his diet. He has limited his intake of sugar through sodas and alcohol, while also giving up some of his favorite foods. That includes Raising Canes.

“That’s a tough one,” Vander Esch admitted. “But I still love it. I still eat it. That’s like a cheat day something for me.”

MORE COWBOYS COVERAGE

FEATURE: Cowboys owner Jerry Jones talks return to Oxnard, Dak Prescott & more!

Hall of Famer Troy Aikman visits Cowboys Camp, talks Dak Prescott

Cowboys running back opens up about fumbles, vaccine controversy


Loading...